-
#Adaptimmune Therapeutics$ADAP corporate presentation (comprises more than the Leerink 7 slides): http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjgwMDg0fENoaWxkSUQ9Mzg5Mzc0fFR5cGU9MQ==&t=1 …$BLUE$AFMD$NKpic.twitter.com/FRf4GhNgOt
-
I'm all in
#Adaptimmune Therapeutics plc$ADAP$TRIL$AFMD$PIRS$NTLA$EDIT$CRSP$CLLS$BLUE$XON$ZIOP$SGMO$NK$ONCE$FATE$INO$BLCM$JUNO$GILD$GSK$NVS$MRK$BMY$BGNE$HCM$BYSI$CALA$CELG$REGN$BIIB$LLY$SNY$PFE$BAYRY$RHHBY$ABBV$NH$FMI$MRNS$MGNX$QURE$GWPHpic.twitter.com/PrEUJcJxhx
-
Beach vacation or lunch time at
@NavyYardPhila? You decide#Adaptimmune pic.twitter.com/ejJF35Z9Oe
-
#Adaptimmune Adaptimmune Therapeutics Proposes Public Offering of American Depositary Shares http://goo.gl/GA3MfB pic.twitter.com/3cKkQJfe5i
-
Perhaps AI can be helpful in distinguishing pseudo progression in immune onc and TCR/Car-t therapies as well
$adap/#adaptimmune ,$BMY,$alrnhttps://twitter.com/CleClinicMD/status/1206652943916838912 … -
Bocce is heating up at
#Adaptimmune summer party
pic.twitter.com/J4m0VJtUG0
-
#Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells$ADAP http://www.1stoncology.com/blog/adaptimmune-announces-first-patient-to-receive-one-billion-target-cell-dose-after-positive-safety-data-from-pilot-study-with-mage-a4-spear-t-cells … -
I was giving a speech to scientists at
#oxforduniversity to talk about#stroke and#aphasia and my path to a career in science
#hope#rebuildinglives#cancer#SPEAR#TCR#adaptimmune pic.twitter.com/FGBXOzcmDn
-
GSK exercises global licence option for
#Adaptimmune's NY-ESO-1 T-cell therapy ... Read more: http://owler.us/adg6e4$ADAP -
#Adaptimmune GSK licenses promising cancer treatment for up to $61 million. Read more: http://owler.us/adgIOR$ADAP -
Its a beautiful day for a bike ride!
@Adaptimmune has bikes you can sign out to grab lunch or ride around@NavyYardPhila#Perks#Adaptimmune pic.twitter.com/kpxQETC4Mp
-
#Astellas swoops in for#Adaptimmune deal a day after positive data https://www.biopharmadive.com/news/astellas-adaptimmune-cancer-cell-therapy-deal/570389/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202020-01-14%20BioPharma%20Dive%20%5Bissue:25126%5D&utm_term=BioPharma%20Dive … via@BioPharmaDive -
#Adaptimmune$ADAP confirms$GSK Nomination of Second Adaptimmune Target under Strategic Multi-Target Collaboration http://www.1stoncology.com/blog/adaptimmune-confirms-gsk-nomination-of-second-adaptimmune-target-under-strategic-multi-target-collaboration … -
Great to work for
@Adaptimmune again! This time at their brand new premises#adaptimmune#posterboardspic.twitter.com/LZtfuRa6EO
-
IBI Blogs On Trading/Investing Secrets: Could Aimmune Be Your Big Payday? https://seekingalpha.com/instablog/17806842-biosci-capital-partners/5396822-ibi-blogs-on-trading-investing-secrets-aimmune-be-your-big-payday …
#DrTranBioSci#Biotech#StocksToWatch#Investments#AimmuneTherapeutics#Adaptimmune#Esperion#ImmunoGen#Exelixis$EXEL$ESPR$AIMT$ADAPpic.twitter.com/LfYuZsthXf
-
#Adaptimmune GlaxoSmithKline Exercises Option Over SPEAR T-Cell Therapy Program Targeting N... Read more: http://owler.us/adgotv$ADAP -
#Adaptimmune to Present at Upcoming CAR-TCR Summit; CEO James Noble to be a Keynote Speaker. Read more: http://owler.us/adeOEK$ADAP
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.